Join or Renew Your Membership Join

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Safety, Tolerability and Immunogenicity of Natalizumab: Results from the AFFIRM Trial
MS and Related Diseases
(-)
004
Authors/Disclosures
No disclosure on file
Chai Lim No disclosure on file
Gill Webster, PhD No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file